IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert DeHaven who wrote (74)	5/5/1997 8:07:00 PM
From: Robert DeHaven	of 1510

Mark: I called the customer relations gal and asked a few questions. These were as follows: 1.) What exactly was discussed in the conference call...."A review of the previous four press releases" 2.) Why did the insiders buy the private placement......"They went before the board and asked for approval". "They agreed to pay more than the current market price so to not be construed unfair to other investors". 3.) Did they arrange financing for the purchase....."Yes, The board required full financial disclosure. "They will pay cash for the purchase." 4.) Do they have any insider information...."No, they have a strong belief in Remune and its prospects." "They do not have any advance firm knowledge trials of how they will come out" 5.) Will the company need any additional capital in the near future...."No the next 12 months cash flow is ok" 6.) If however, the market price achieves $15 or higher then some additional financing will/might take place to take advantage of the more favorable environment. This was from the investor relations company. More from the street...as I pick it up.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next